Burden of Invasive Pneumococcal Disease and Community-Acquired Pneumonia in Adults: Significant Adverse Outcomes and Costs beyond Direct Treatment
Jenni Kononoff, Veli-Jukka Anttila, Peter Klemets, Marita Kalaoja, Mari Pölkki, Maarit J Korhonen · 2026
Read Burden of Invasive Pneumococcal Disease and Community-Acquired Pneumonia in Adults: Significant Adverse Outcomes and Costs beyond Direct Treatment by Jenni Kononoff, Veli-Jukka Anttila, Peter Klemets, Marita Kalaoja, Mari Pölkki, Maarit J Korhonen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13279831.txt.
Description
Jenni Kononoff and co-authors measured the full burden of two lung infections across Finland: invasive pneumococcal disease and community-acquired pneumonia. They linked national records for nearly 2,900 confirmed invasive cases and more than a quarter million pneumonia cases, then followed patients for later harm and costs. Matched controls numbered over 760,000.
Between forty and sixty percent of patients carried at least one known risk factor, yet a large share of older patients had none. Older patients with the invasive disease or hospital-treated pneumonia fared worst, with more repeat illness, more moves into institutional care, and more heart attacks. Costs ran well past the treatment itself, through wider healthcare use and lost work. Vaccine-covered strains still caused most older cases, the team notes, which keeps prevention on the table.
Catalog record
| CREATOR | Jenni Kononoff, Veli-Jukka Anttila, Peter Klemets, Marita Kalaoja, Mari Pölkki, Maarit J Korhonen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |